ÂÜÀòÂÒÂ×

Pam Stetkiewicz joined Arbor in July 2021 from Flagship Pioneering, where she was Senior Vice President, Global Program Leader at Flagship Pioneering Medicines. Pam brings more than 20 years of extensive life-sciences pharmaceutical experience with recent experience at Editas Medicine as Vice President, Program and Alliance Management. Pam was brought into the leadership team to build the development organization, form collaborations and notably led the team that filed the first IND for an in vivo CRISPR therapeutic (EDIT-101 for LCA10). Prior to that, Pam worked at Novartis Institute of Biomedical Research for 13 years, in a variety of roles across science, alliance, project and portfolio management. Her last role at Novartis was as Executive Director, in Strategic Alliances which involved early business development and collaborations with external companies.

Pam received her Ph.D. from Johns Hopkins University and a B.S. from the University of Rhode Island.